Pharos iBio Co., Ltd. (KOSDAQ: 388870)
South Korea
· Delayed Price · Currency is KRW 10,020
+420 (4.38%)
Sep 11, 2024, 3:00 PM KST
Pharos iBio Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -10,493 | -8,858 | -17,062 | -31,471 | -13,398 | -4,951 |
| Depreciation & Amortization | 756.76 | 684.91 | 578.1 | 350.09 | 155.37 | 116.86 |
| Loss (Gain) From Sale of Assets | 78.96 | 41.7 | -24.43 | -3.2 | - | - |
| Loss (Gain) From Sale of Investments | - | - | - | - | 27.15 | -17.83 |
| Stock-Based Compensation | 484.96 | 533.61 | 618.15 | 386.27 | 168.3 | 581.85 |
| Other Operating Activities | -321.18 | 15.56 | 7,683 | 24,007 | 7,672 | 2,355 |
| Change in Accounts Receivable | - | - | - | - | 17.41 | -17.41 |
| Change in Inventory | - | - | - | - | - | 7.74 |
| Change in Accounts Payable | - | - | - | - | - | -2.02 |
| Change in Other Net Operating Assets | -68.64 | 169.48 | 22.76 | -588.38 | 71.5 | -360.46 |
| Operating Cash Flow | -9,562 | -7,413 | -8,184 | -7,319 | -5,287 | -2,288 |
| Capital Expenditures | -923.79 | -839.64 | -328.28 | -1,170 | -264.38 | -72.6 |
| Sale of Property, Plant & Equipment | 4 | 4 | 46.32 | 14.55 | - | - |
| Sale (Purchase) of Intangibles | 0.04 | -15.1 | -5.8 | -310.81 | -21.18 | - |
| Investment in Securities | -6,585 | 1,368 | -6,267 | - | -3,926 | -740.68 |
| Other Investing Activities | 116.62 | -43.18 | -11.92 | -91.25 | -6.5 | -0.7 |
| Investing Cash Flow | -7,388 | 474.34 | -6,567 | -1,557 | -4,218 | -813.97 |
| Long-Term Debt Repaid | - | -267.2 | -271.11 | -383.72 | -131.58 | -18.75 |
| Net Debt Issued (Repaid) | -206.38 | -267.2 | -271.11 | -383.72 | -131.58 | -18.75 |
| Issuance of Common Stock | 19,073 | 19,073 | - | - | 41.03 | - |
| Other Financing Activities | -0 | -0 | - | -2 | 2 | - |
| Financing Cash Flow | 18,866 | 18,805 | -271.11 | 17,635 | 15,906 | -18.75 |
| Foreign Exchange Rate Adjustments | 411.21 | -90.8 | 21.67 | 246.65 | -195.92 | 1.45 |
| Net Cash Flow | 2,327 | 11,776 | -15,000 | 9,005 | 6,205 | -3,119 |
| Free Cash Flow | -10,486 | -8,253 | -8,512 | -8,489 | -5,551 | -2,361 |
| Free Cash Flow Margin | - | - | -2837.42% | -14892.94% | -2957.82% | -560.57% |
| Free Cash Flow Per Share | -818.23 | -681.98 | -958.45 | -1462.70 | -981.82 | -425.26 |
| Cash Interest Paid | 5.37 | 6.69 | 16.94 | 17.68 | 22.15 | 22.89 |
| Cash Income Tax Paid | 12.54 | 74.11 | 10.01 | 6.62 | -0.36 | 7.05 |
| Levered Free Cash Flow | - | -6,202 | -50,167 | 14,875 | 2,769 | - |
| Unlevered Free Cash Flow | - | -6,195 | -48,153 | 18,946 | 5,443 | - |
| Change in Net Working Capital | - | -297.93 | 41,760 | -25,330 | -9,352 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.